Literature DB >> 23054950

Pancreatic neuroendocrine tumors.

Shailesh V Shrikhande1, Bhawna Sirohi, Mahesh Goel, Savio G Barreto.   

Abstract

Pancreatic neuroendocrine tumors (pancreatic NETs) are rare, low- to intermediate-grade neoplasms thought to arise from the pancreatic islets. Recent advances in pathology and our understanding of the biological behavior of this group of tumors has resulted in changes in their nomenclature and how we treat them. This review puts into perspective our current understanding of pancreatic NETs in terms of their incidence, pathology, and management.

Entities:  

Mesh：

Year:  2012        PMID： 23054950     DOI： 10.1007/s12664-012-0257-2

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


  156 in total

1.  Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.

Authors:  Rakesh Kumar; Punit Sharma; Pramod Garg; Sellam Karunanithi; Niraj Naswa; Raju Sharma; Sanjay Thulkar; Sneh Lata; Arun Malhotra
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

2.  Insulinoma: diagnosis with fat-suppressed MR imaging.

Authors:  B B Kraus; P R Ros
Journal:  AJR Am J Roentgenol       Date:  1994-01       Impact factor: 3.959

Review 3.  Gastroenteropancreatic neuroendocrine tumors: multimodality imaging features with pathological correlation.

Authors:  Daichi Hayashi; Jaroslaw N Tkacz; Stephen Hammond; Brooke C Devenney-Cakir; Souhil Zaim; Nadia Bouzegaou; Souhila Ounadjela; Ali Guermazi
Journal:  Jpn J Radiol       Date:  2011-02-27       Impact factor: 2.374

4.  Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.

Authors:  J A Norton; H R Alexander; D L Fraker; D J Venzon; F Gibril; R T Jensen
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

5.  Preoperative localisation and surgical management of insulinoma: single centre experience.

Authors:  Vibha Varma; Laura Tariciotti; Christopher Coldham; Phillipe Taniere; John A Buckels; Simon R Bramhall
Journal:  Dig Surg       Date:  2011-02-04       Impact factor: 2.588

6.  Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.

Authors:  L J Hofland; W W de Herder; M Waaijers; J Zuijderwijk; P Uitterlinden; P M van Koetsveld; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

7.  5-year review and reappraisal of ultrasound-guided percutaneous transabdominal fine needle aspiration of pancreatic lesions.

Authors:  Prateek Bhatia; Radhika Srinivasan; Arvind Rajwanshi; Raje Nijhawan; Niranjan Khandelwal; Jaidev Wig; Rakesh K Vasishtha
Journal:  Acta Cytol       Date:  2008 Sep-Oct       Impact factor: 2.319

8.  Transarterial liver-directed therapies of neuroendocrine hepatic metastases.

Authors:  Javier Nazario; Sanjay Gupta
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

Review 9.  Lutetium-labelled peptides for therapy of neuroendocrine tumours.

Authors:  B L R Kam; J J M Teunissen; E P Krenning; W W de Herder; S Khan; E I van Vliet; D J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064
View more
  2 in total

1.  Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.

Authors:  Sandip Basu; Bhawna Sirohi; Shailesh V Shrikhande
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-27       Impact factor: 9.236

2.  Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a Distinct Entity.

Authors:  Vinay Gaikwad; Shraddha Patkar; Savio George Barreto; Bhawna Sirohi; Mahesh Goel; Shailesh V Shrikhande
Journal:  Indian J Surg       Date:  2016-02-13       Impact factor: 0.656
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.